Literature DB >> 12364644

Non-Hodgkin's lymphoma in a patient with refractory dermatomyositis which had been treated with infliximab.

E Roddy, P A Courtney, A Morris.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12364644     DOI: 10.1093/rheumatology/41.10.1194

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  9 in total

Review 1.  Biologics in inflammatory disease: infliximab associated risk of lymphoma development.

Authors:  C Bucher; L Degen; S Dirnhofer; M Pless; R Herrmann; P Schraml; P Went
Journal:  Gut       Date:  2005-05       Impact factor: 23.059

2.  Long-standing refractory polymyositis responding to mycophenolate mofetil: a case report and review of the literature.

Authors:  Paola Caramaschi; Alessandro Volpe; Antonio Carletto; Lisa M Bambara; Domenico Biasi
Journal:  Clin Rheumatol       Date:  2007-01-17       Impact factor: 2.980

Review 3.  Is there truly a risk of lymphoma from biologic therapies?

Authors:  Erica Dommasch; Joel M Gelfand
Journal:  Dermatol Ther       Date:  2009 Sep-Oct       Impact factor: 2.851

4.  Sources of information on lymphoma associated with anti-tumour necrosis factor agents: comparison of published case reports and cases reported to the French pharmacovigilance system.

Authors:  Hélène Théophile; Thierry Schaeverbeke; Ghada Miremont-Salamé; Abdelilah Abouelfath; Valentine Kahn; Françoise Haramburu; Bernard Bégaud
Journal:  Drug Saf       Date:  2011-07-01       Impact factor: 5.606

Review 5.  [Off-label use of infliximab].

Authors:  M Onder; C Salavastru; K Fritz
Journal:  Hautarzt       Date:  2013-10       Impact factor: 0.751

Review 6.  Tumor necrosis factor-alpha as a potential therapeutic target in idiopathic inflammatory myopathies.

Authors:  Joerg-Patrick Stübgen
Journal:  J Neurol       Date:  2011-01-21       Impact factor: 6.682

Review 7.  New onset of dermatomyositis/polymyositis during anti-TNF-α therapies: a systematic literature review.

Authors:  Alexandra Maria Giovanna Brunasso; Werner Aberer; Cesare Massone
Journal:  ScientificWorldJournal       Date:  2014-01-29

Review 8.  Advancements in the Treatment of Cutaneous Lupus Erythematosus and Dermatomyositis: A Review of the Literature.

Authors:  Kareem G Elhage; Raymond Zhao; Mio Nakamura
Journal:  Clin Cosmet Investig Dermatol       Date:  2022-09-08

Review 9.  Biologics in dermatology: an integrated review.

Authors:  Virendra N Sehgal; Deepika Pandhi; Ananta Khurana
Journal:  Indian J Dermatol       Date:  2014-09       Impact factor: 1.494

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.